Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah Ashby is active.

Publication


Featured researches published by Deborah Ashby.


Health Technology Assessment | 2012

Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries

Sarah E Lamb; Mark A. Williams; Esther M Williamson; Simon Gates; Emma J Withers; Shahrul Mt-Isa; Deborah Ashby; Emanuela Castelnuovo; Martin Underwood; Matthew Cooke

OBJECTIVESnTo examine the clinical effectiveness of a stepped care approach over a 12-month period after an acute whiplash injury; to estimate the costs and cost-effectiveness of each strategy including treatments and subsequent health-care costs; and to gain participants perspective on experiencing whiplash injury, NHS treatment, and recovery within the context of the Managing Injuries of the Neck Trial (MINT).nnnDESIGNnTwo linked, pragmatic, randomised controlled trials. In Step 1, emergency departments (EDs) were cluster randomised to usual care advice (UCA) or The Whiplash Book advice (WBA)/active management advice. In Step 2, participants were individually randomised to either a single session of advice from a physiotherapist or a physiotherapy package of up to six sessions. An economic evaluation and qualitative study were run in parallel with the trial.nnnSETTINGnTwelve NHS trusts in England comprising 15 EDs.nnnPARTICIPANTSnPeople who attended EDs with an acute whiplash injury of whiplash-associated disorder grades I-III were eligible for Step 1. People who had attended EDs with whiplash injuries and had persistent symptoms 3 weeks after ED attendance were eligible for Step 2.nnnINTERVENTIONSnIn Step 1, the control intervention was UCA and the experimental intervention was a psycho-educational intervention (WBA/active management advice). In Step 2 the control treatment was reinforcement of the advice provided in Step 1 and the experimental intervention was a package of up to six physiotherapy treatments.nnnMAIN OUTCOMEnThe primary outcome was the Neck Disability Index (NDI), which measures severity and frequency of pain and symptoms, and a range of activities including self-care, driving, reading, sleeping and recreation. Secondary outcomes included the mental and physical health-related quality-of-life (HRQoL) subscales of the Short Form questionnaire-12 items (SF-12) and the number of work days lost.nnnRESULTSnA total of 3851 patients were recruited to Step 1 of the trial. 1598 patients attending EDs were randomised to UCA, and 2253 were randomised to WBA/active management. Outcome data were obtained at 12 months for 70% and 80% of participants at Step 1 and Step 2, respectively. The majority of people recovered from the injury. Eighteen per cent of the Step 1 cohort had late whiplash syndrome. There was no statistically or clinically significant difference observed in any of the outcomes for participants attending EDs randomised to UCA or active management advice [difference in NDI 0.5, 95% confidence interval (CI) -1.8 to 2.8]. In Step 2 the physiotherapy package resulted in improvements in neck disability at 4 months compared with a single advice session, but these effects were small at the population level (difference in NDI -3.2, 95% CI -5.8 to -0.7). The physiotherapy package was accompanied by a significant reduction in the number of work days lost at 4-month follow-up (difference -40.2, 95% CI -44.3 to -35.8).nnnCONCLUSIONSnMINT suggests that enhanced psycho-educational interventions in EDs are no more effective than UCA in reducing the burden of acute whiplash injuries. A physiotherapy package provided to people who have persisting symptoms within the first 6 weeks of injury produced additional short-term benefits in neck disability compared with a single physiotherapy advice session. However, from a health-care perspective, the physiotherapy package was not cost-effective at current levels of willingness to pay. Both experimental treatments were associated with increased cost with no discernible gain in health-related quality of life. However, an important benefit of the physiotherapy package was a reduction in work days lost; consequently, the intervention may prove cost-effective at the societal level.nnnTRIAL REGISTRATIONnCurrent Controlled Trials ISRCTN33302125.nnnFUNDINGnThis project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 16, No. 49. See the HTA programme website for further project information.


Annals of Clinical Biochemistry | 1986

Long-Term Trends in Biochemical Data Obtained from Two Population Surveys:

P M G Broughton; Roger Holder; Deborah Ashby

A study has been made of the variations in monthly mean values of 10 serum constituents in subjects participating in two partly-concurrent long-term epidemiological surveys. Closely similar patterns of variation were found in men in both surveys and in men and women in one survey. During the 6 years of the study, four types of variation of the monthly mean concentrations were identified in varying combinations: (i) abrupt changes of less than 2% not detected by quality control procedures; (ii) a gradual drift in mean value; (iii) haphazard variations in mean values; and (iv) seasonal variations in bilirubin and urea, identical in men and women. The implications of these findings for the design of long-term epidemiological surveys, and the criteria for designating variations as seasonal, are discussed.


Investigative Ophthalmology & Visual Science | 2006

Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis.

Alicja R. Rudnicka; Shahrul Mt-Isa; Christopher G. Owen; Deborah Ashby


Pediatric Pulmonology | 2002

Cytokines in severe respiratory syncytial virus bronchiolitis

Kevin J. Mobbs; Rosalind L. Smyth; Una O'Hea; Deborah Ashby; Paul Ritson; C. Anthony Hart


Pharmacoepidemiology and Drug Safety | 2003

Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry

Judith Strobl; Ian Enzer; Adrian Bagust; Alan Haycox; Rosalind L. Smyth; Deborah Ashby; Tom Walley


Archive | 2017

GeneticLociAssociatedWithC-ReactiveProtein Levels and Risk of Coronary Heart Disease

Paul Elliott; John Campbell Chambers; Weihua Zhang; Robert Clarke; Jemma C. Hopewell; John F. Peden; Jeanette Erdmann; Peter S. Braund; James C. Engert; Derrick Bennett; Lachlan Coin; Deborah Ashby; Ioanna Tzoulaki; Ian J. Brown; Shahrul Mt-Isa; Mark I. McCarthy; Leena Peltonen; Nelson B. Freimer; Martin Farrall; Aimo Ruokonen; Anders Hamsten; Noha Lim; Philippe Froguel; Dawn Waterworth; Peter Vollenweider; Waeber G


Archive | 2012

trials in primary care Lessons for cluster randomized trials in the twenty-first century: a systematic review of

Sandra Eldridge; Deborah Ashby; Gene Feder; Alicja R. Rudnicka; Obioha C. Ukoumunne


Archive | 2005

MHRA's safety review randomised controlled trials submitted to the company data from placebo controlled, and suicide in adults: meta-analysis of drug Selective serotonin reuptake inhibitors (SSRIs)

David Gunnell; Julia Saperia; Deborah Ashby


Archive | 2004

balance of benefit and harm Antidepressants and suicide: what is the

David Gunnell; Deborah Ashby


BMJ | 2004

Antidepressants and suicide: Authors' reply

David Gunnell; Deborah Ashby

Collaboration


Dive into the Deborah Ashby's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alicja R. Rudnicka

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan Haycox

University of Liverpool

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Derrick Bennett

Clinical Trial Service Unit

View shared research outputs
Researchain Logo
Decentralizing Knowledge